EVEA™ IntraVaginal Culture (IVC) lets healthcare networks deliver assisted reproduction — without the cleanroom, without a dedicated embryology laboratory, without the infrastructure barrier.
Request a briefing →In underserved markets, fertility care is constrained less by demand than by infrastructure — the embryology laboratory every conventional IVF cycle depends on. Eve exists to lift that constraint. By relocating the multi-day culture phase in-vivo, EVEA™ lets hospitals use their existing operating theatre, andrology lab and embryology staff — while eliminating the cleanroom, incubator bank and HEPA filtration that make conventional IVF impractical in secondary cities. Our focus is Asia-Pacific, and in particular the secondary cities and underserved regions conventional infrastructure has never reached.
Eve develops EVEA™, an intravaginal culture device, and the activation platform around it — built to medical-device regulatory and manufacturing standards.
Eve earns a recurring per-cycle platform fee. We grow as our partners run more cycles — our incentives are aligned with theirs.
One activation model, deployed site by site across Asia-Pacific — recurring on participation rather than tied to infrastructure we own.
Built for Asia-Pacific — to bring advanced fertility care to the secondary cities and underserved regions that conventional embryology infrastructure does not reach.
EVEA™ decentralizes the culture phase, so a hospital may offer selected assisted-reproduction services without building the full embryology infrastructure a major urban IVF centre requires.
Eve is led by a team combining deep MedTech commercial experience with clinical and regulatory expertise — Founder & CEO Yve Lyppens and Co-Founder & Director of Medical Affairs Col. Dr. Othman Sukhilmi.
Meet the team →Eve Fertility Ltd. is incorporated in Hong Kong SAR, with an active deployment pipeline across Asia-Pacific — the secondary-city hospital systems where fertility infrastructure does not yet exist.
For hospital systems, fertility operators, investors, regulators and partners across Asia-Pacific.
Request a briefing → Explore EVEA™